ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration

Zhong, Zhihui, Deane, Rashid, Ali, Zarina, Parisi, Margaret, Shapovalov, Yuriy, O'Banion, M Kerry, Stojanovic, Konstantin, Sagare, Abhay +3 more·2008·Nature Neuroscience

Cited by (476)

Items 101–200 of 476

  1. Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit
    Gesine Paul, Osama F. Elabi · 2022 · Frontiers in Aging Neuroscience
  2. Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
    Michael Jablonski, Shashirekha S. Markandaiah, Dena A. Jacob, Ni J. Meng, Ke Li, Victoria J. Gennaro, Angelo C. Lepore, Davide Trotti, Piera Pasinelli · 2014 · Annals of Clinical and Translational Neurology
  3. Towards Retinoid Therapy for Alzheimers Disease
    Shudo, K., Fukasawa, H., Nakagomi, M., Yamagata, N. · 2009 · Current Alzheimer Research
  4. The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies
    Sophie Dithmer, Ingolf Ernst Blasig, P. A. Fraser, Zhihai Qin, Reiner F. Haseloff · 2024 · International Journal of Molecular Sciences
  5. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis
    Giovanni Nardo, Raffaele Iennaco, Nicolò Fusi, Paul Roy Heath, Marianna Marino, Maria Chiara Trolese, Laura Ferraiuolo, Neil David Lawrence, Pamela J. Shaw, Caterina Bendotti · 2013 · Brain
  6. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    Federica Rizzo, Giulietta Maria Riboldi, Sabrina Salani, Monica Nizzardo, Chiara Simone, Stefania Paola Corti, Eva Hedlund · 2013 · Cellular and Molecular Life Sciences
  7. The Role of Neurovascular System in Neurodegenerative Diseases
    Ajmal Ahmad, Vanisha Patel, Jianfeng Xiao, Mohammad Moshahid Khan · 2020 · Molecular Neurobiology
  8. Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
    Ying‐Chieh Wu, Tuuli-Maria Sonninen, Sanni Peltonen, Jari Koıstınaho, Šárka Lehtonen · 2021 · International Journal of Molecular Sciences
  9. Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS
    Anna Wuolikainen, Thomas Möritz, Stefan L. Marklund, Henrik Antti, Peter Munch Andersen · 2011 · PLoS ONE
  10. Selective increase of two ABC drug efflux transporters at the blood–spinal cord barrier suggests induced pharmacoresistance in ALS
    Michael Jablonski, Dena A. Jacob, Christopher R. Campos, David S. Miller, Nicholas John Maragakis, Piera Pasinelli, Davide Trotti · 2012 · Neurobiology of Disease
  11. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases
    Afshin Babazadeh, Fereshteh Mohammadi Vahed, Seid Mahdi Jafari · 2020 · Journal of Controlled Release
  12. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
    Miles S. Lyon, Marlena Wosiski‐Kuhn, Rachel Gillespie, James B. Caress, Carol Milligan · 2018 · Muscle & Nerve
  13. Cerebrovascular disorders: molecular insights and therapeutic opportunities
    Erik Storkebaum, Annelies Quaegebeur, Miikka Vikkula, Peter Carmeliet · 2011 · Nature Neuroscience
  14. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium
    Michela Ferrucci, Alida Spalloni, Alessia Bartalucci, Emanuela Cantafora, Federica Fulceri, Michele Nutini, Patrizia Longone, Antonio Paparelli, Francesco Fornai · 2009 · Neurobiology of Disease
  15. Nano-scale architecture of blood-brain barrier tight-junctions
    Esther Sasson, Shira Anzi, Batia Bell, Oren Yakovian, Meshi Zorsky, Urban Deutsch, Britta Engelhardt, Eilon Sherman, Gad David Vatine, Ron Dzikowski et al. · 2021 · eLife
  16. Lithium Upregulates Vascular Endothelial Growth Factor in Brain Endothelial Cells and Astrocytes
    Shuzhen Guo, Ken Arai, Monique F. Stins, De‐Maw Chuang, Eng H. Lo · 2008 · Stroke
  17. Pericytes: Blood-Brain Barrier Safeguards against Neurodegeneration?
    Annelies Quaegebeur, Inmaculada Segura, Peter Carmeliet · 2010 · Neuron
  18. The neurobiology of amyotrophic lateral sclerosis
    André Bento‐Abreu, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht · 2010 · European Journal of Neuroscience
  19. Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
    Shigeko Takeuchi, Noriko Fujiwara, Akemi Ido, Miki Oono, Yuki Takeuchi, Minako Tateno, Keiichiro Suzuki, Ryosuke Takahashi, Ikuo Tooyama, Naoyuki Taniguchi et al. · 2010 · Journal of Neuropathology & Experimental Neurology
  20. Claudins: unlocking the code to tight junction function during embryogenesis and in disease
    IR Gupta, Aimee K. Ryan · 2010 · Clinical Genetics
  21. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis
    Marcel Maier, Tobias Welt, Fabian Wirth, Fabio Montrasio, Daniel F. Preisig, Jordan McAfoose, Fernando G. Vieira, Luka Kulic, Claudia B. Späni, Thilo Stehle et al. · 2018 · Science Translational Medicine
  22. Blood-retina barrier failure and vision loss in neuron-specific degeneration
    Elena Ivanova, Nazia M. Alam, Glen T. Prusky, Botir T. Sagdullaev · 2019 · JCI Insight
  23. Basal lamina changes in neurodegenerative disorders
    Nguyen, Benjamin, Bix, Gregory, Yao, Yao · 2021 · Molecular Neurodegeneration
  24. Unique biology of gliomas: challenges and opportunities
    Stacey Watkins, Harald W. Sontheimer · 2012 · Trends in Neurosciences
  25. Small Vessels Are a Big Problem in Neurodegeneration and Neuroprotection
    Şefik Evren Erdener, Turgay Dalkara · 2019 · Frontiers in Neurology
  26. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain
    Hassan Pezeshgi Modarres, Mohsen Janmaleki, Mana Novin, John Saliba, Fatima El Hajj Moussa, Mahdi Rezayati Charan, Amir Seyfoori, Hamid SadAbadi, Milène Vandal, Minh Dang Nguyen et al. · 2018 · Journal of Controlled Release
  27. Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels
    Max I. Bogorad, Jackson G. DeStefano, Raleigh M. Linville, Andrew D. Wong, Peter C. Searson · 2019 · Journal of Cerebral Blood Flow & Metabolism
  28. Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
    Tereza Filipi, Zuzana Heřmanová, Jana Turečková, Ondřej Vaňátko, Miroslava Anděrová · 2020 · Journal of Clinical Medicine
  29. Targeting the neurovascular unit for treatment of neurological disorders
    Reyna L. VanGilder, Charles Lee Rosen, Taura L. Barr, Jason Delwyn Huber · 2010 · Pharmacology & Therapeutics
  30. Early and Progressive Impairment of Spinal Blood Flow—Glucose Metabolism Coupling in Motor Neuron Degeneration of ALS Model Mice
    Kazunori Miyazaki, Kazuto Masamoto, Nobutoshi Morimoto, Tomoko Kurata, Takahumi Mimoto, Takayuki Obata, Iwao Kanno, Koji Abe · 2011 · Journal of Cerebral Blood Flow & Metabolism
  31. The dual roles of immunity in ALS: Injury overrides protection
    Benjamin J. Murdock, Diane E. Bender, Benjamin M. Segal, Eva L. Feldman · 2015 · Neurobiology of Disease
  32. The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model
    Moriah E. Katt, Lakyn N. Mayo, Shannon Ellis, Vasiliki Mahairaki, Jeffrey D. Rothstein, Linzhao Cheng, Peter C. Searson · 2019 · Fluids and Barriers of the CNS
  33. Distribution, Differentiation, and Survival of Intravenously Administered Neural Stem Cells in a Rat Model of Amyotrophic Lateral Sclerosis
    Dinko Mitrečić, Charles Nicaise, Srečko Gajović, Roland Pochet · 2010 · Cell Transplantation
  34. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis
    Stefania Paola Corti, Monica Nizzardo, Martina Nardini, Chiara Donadoni, Sabrina Salani, Chiara Simone, Marianna Falcone, Giulietta Maria Riboldi, Alessandra Govoni, Nereo Bresolin et al. · 2010 · Human Molecular Genetics
  35. The neurovascular link in health and disease: an update
    Inmaculada Segura, Frederik De Smet, Philipp J. Hohensinner, Carmen Ruiz de Almodóvar, Peter Carmeliet · 2009 · Trends in Molecular Medicine
  36. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
    Zhouyang Liu, Xi Cheng, Shanshan Zhong, Xiuchun Zhang, Chang Liu, Fangxi Liu, Chuansheng Zhao · 2020 · Frontiers in Neuroscience
  37. 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice
    Divna Lazić, Abhay P. Sagare, Angeliki Maria Nikolakopoulou, John H. Griffin, Robert J. Vassar, Berislav V. Zloković · 2019 · The Journal of Experimental Medicine
  38. Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention
    Mauro Cozzolino, Maria Grazia Pesaresi, Valeria Gerbino, Julian Großkreutz, Maria Teresa Carrı̀ · 2012 · Antioxidants and Redox Signaling
  39. In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS
    Payam Dibaj, Heinz Steffens, Jana Zschüntzsch, Fabien Nadrigny, Eike Dieter Schomburg, Frank Kirchhoff, Clemens Neusch · 2011 · PLoS ONE
  40. High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity
    Hisham Qosa, Loqman A. Mohamed, Sweilem B. Al Rihani, Yazan S. Batarseh, Quoc-Viet Duong, Jeffrey N. Keller, Amal Kaddoumi · 2016 · Journal of Alzheimer s Disease
  41. Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
    Moritz Steinruecke, Rebecca Murphy Lonergan, Bhuvaneish Thangaraj Selvaraj, Siddharthan Chandran, Blanca Díaz Castro, Maria Stavrou · 2023 · Journal of Cerebral Blood Flow & Metabolism
  42. Particulate matter exposure and neurodegenerative diseases: A comprehensive update on toxicity and mechanisms
    Jeongmin Lee, Poornima D. E. Weerasinghe-Mudiyanselage, Bohye Kim, Sohi Kang, Joong‐Sun Kim, Changjong Moon · 2023 · Ecotoxicology and Environmental Safety
  43. CSF markers in amyotrophic lateral sclerosis
    Joanna Tarasiuk, Alina Kułakowska, Wiesław Drozdowski, Johannes Kornhuber, Piotr Lewczuk · 2012 · Journal of Neural Transmission
  44. Interleukin-34 Restores Blood–Brain Barrier Integrity by Upregulating Tight Junction Proteins in Endothelial Cells
    Shijie Jin, Yoshifumi Sonobe, Jun Kawanokuchi, Hiroshi Horiuchi, Yi Hsuan Cheng, Yue Wang, Tetsuya Mizuno, Hideyuki Takeuchi, Akio Suzumura · 2014 · PLoS ONE
  45. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration
    Bettina Schmid, Christian Haass · 2013 · Journal of Neurochemistry
  46. Aquaporin‐4 Overexpression in Rat ALS Model
    Charles Nicaise, Muhammad Shahnawaz Soyfoo, Michèle Authelet, Robert De Decker, Danijela Bataveljić, Christine Delporte, Roland Pochet · 2008 · The Anatomical Record
  47. Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy
    Eilidh Somers, Z. Stencel, Thomas M. Wishart, Thomas Henry Gillingwater, Simon H. Parson · 2011 · Neuromuscular Disorders
  48. Advances in the application of MRI to amyotrophic lateral sclerosis
    Martin R. Turner, Michel Modo · 2010 · Expert Opinion on Medical Diagnostics
  49. <i>In Vivo</i> Morphological Changes in Animal Models of Amyotrophic Lateral Sclerosis and Alzheimer's‐Like Disease: MRI Approach
    Andjus, Pavle R., Bataveljić, Danijela, Vanhoutte, Greetje, Mitrecic, Dinko, Pizzolante, Fabrizio, Djogo, Nevena, Nicaise, Charles, Kengne, Fabrice Gankam, Gangitano, Carlo, Michetti, Fabrizio et al. · 2009 · The Anatomical Record
  50. Blood–spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy
    Reine‐Solange Sauer, Juliane Kirchner, Shaobing Yang, Liu Hu, Mathias Leinders, Claudia Sommer, Alexander Brack, Heike Lydia Rittner · 2017 · Annals of the New York Academy of Sciences
  51. Repurposing metformin to treat age-related neurodegenerative disorders and ischemic stroke
    Sejal Sharma, Saeideh Nozohouri, Bhuvaneshwar Vaidya, Thomas J. Abbruscato · 2021 · Life Sciences
  52. Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis
    Atsushi Kasai, Toshihiko Kinjo, Rie Ishihara, Ikumi Sakai, Yuki Ishimaru, Yasuhiro Yoshioka, Akiko Yamamuro, Kumiko Ishige, Yoshihisa Ito, Sadaaki Maeda · 2011 · PLoS ONE
  53. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact
    Fabiola De Marchi, Ivana Munitić, Amedeo Amedei, James D. Berry, Eva L. Feldman, Eleonora Aronica, Giovanni Nardo, Donatienne Van Weehaeghe, Elena Niccolai, Nikolina Prtenjača et al. · 2021 · Neuroscience & Biobehavioral Reviews
  54. Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety
    Yijun Pan, Joseph A. Nicolazzo · 2022 · British Journal of Pharmacology
  55. Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats
    Rajeshwar Kumar Yadav, Sidharth Mehan, Rakesh Sahu, Sumit Kumar, Andleeb Khan, Hafiz Antar Makeen, Mohammed Al Bratty · 2022 · Human & Experimental Toxicology
  56. Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
    Jason R. Thonhoff, Luis D. Ojeda, Ping Wu · 2009 · Current Stem Cell Research & Therapy
  57. Motor neuron–immune interactions: the vicious circle of ALS
    Ana G. Barbeito, Pinar Mesci, Séverine Boillée · 2010 · Journal of Neural Transmission
  58. Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity
    Yaoming Wang, Meenakshisundaram Thiyagarajan, Nienwen Chow, Itender Singh, Huang Guo, Thomas P. Davis, Berislav V. Zloković · 2008 · Stroke
  59. Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis
    Ana Catarina Pronto‐Laborinho, Susana Pinto, Mamede A. de Carvalho · 2014 · BioMed Research International
  60. Advances in stem cell research for Amyotrophic Lateral Sclerosis
    Sophia T. Papadeas, Nicholas John Maragakis · 2009 · Current Opinion in Biotechnology
  61. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS
    Inna Rabinovich-Nikitin, Assaf Ezra, Beka Barbiro, Polina Rabinovich‐Toidman, Beka Solomon · 2016 · Journal of Neuroinflammation
  62. Pharmacological targeting of the PDGF-CC signaling pathway for blood–brain barrier restoration in neurological disorders
    Sebastian A. Lewandowski, Linda Fredriksson, Daniel A. Lawrence, Ulf Eriksson · 2016 · Pharmacology & Therapeutics
  63. Brain barriers in health and disease
    Richard Daneman, Britta Engelhardt · 2017 · Neurobiology of Disease
  64. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy
    S. Priya Narayanan, Esraa Shosha, Chithra Devi Palani · 2019 · Pharmacological Research
  65. Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
    Yamir Islam, Andrew G. Leach, Jayden A. Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James R. Downing, Amos A. Fatokun, Meritxell Teixidò, Touraj Ehtezazi · 2021 · Advanced Science
  66. Accelerated Neurodegeneration and Neuroinflammation in Transgenic Mice Expressing P301L Tau Mutant and Tau-Tubulin Kinase 1
    Hirohide Asai, Seiko Ikezu, Maya E. Woodbury, Grant Yonemoto, Libin Cui, Tsuneya Ikezu · 2014 · American Journal Of Pathology
  67. Alterations of the blood‐spinal cord barrier in sporadic amyotrophic lateral sclerosis
    Shoichi Sasaki · 2015 · Neuropathology
  68. Aquaporins in the Spinal Cord
    Michal Krystian Oklinski, Mariusz T Skowronski, Agnieszka Skowrońska, Michael R. Rützler, Kirsten Nørgaard, John D. Nieland, Tae‐Hwan Kwon, Søren Nielsen · 2016 · International Journal of Molecular Sciences
  69. P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
    Gary A. Weisman, Lucas T. Woods, Laurie Erb, Cheikh I. Seye · 2012 · CNS & Neurological Disorders - Drug Targets
  70. Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair
    Svitlana N. Garbuzova-Davis, Crupa Kurien, Avery Thomson, Dimitri Falco, Sohaib Ahmad, Joseph F. Staffetti, George A. Steiner, Sophia Abraham, G. V. James, Ajay Mahendrasah et al. · 2017 · Scientific Reports
  71. VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3‐K pathway and inhibition of p38MAPK
    Luis B. Tovar‐y‐Romo, Ricardo Tapia · 2010 · Journal of Neurochemistry
  72. TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
    Yuting Ren, Siyuan Li, Siyu Chen, Xiao-Sun Sun, Fei Yang, Hongfen Wang, Mao Li, Fang Cui, Xusheng Huang · 2021 · Frontiers in Neurology
  73. Blood-Spinal Cord Barrier: Its Role in Spinal Disorders and Emerging Therapeutic Strategies
    Neha Chopra, Spiro Menounos, Jaesung Peter Choi, Philip M. Hansbro, Ashish Dhar Diwan, Abhirup Das · 2021 · NeuroSci
  74. Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS
    Sarah Waters, Birger Victor Dieriks, Molly E. V. Swanson, Yibin Zhang, Natasha Lillia Grimsey, Helen C. Murray, Clinton P. Turner, Henry John Waldvogel, Richard L. M. Faull, Jiyan An et al. · 2021 · Acta Neuropathologica Communications
  75. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis
    El Oussini, Hajer, Scekic‐Zahirovic, Jelena, Vercruysse, Pauline, Marques, Christine, Dirrig‐Grosch, Sylvie, Dieterlé, Stéphane, Picchiarelli, Gina, Sinniger, Jérôme, Rouaux, Caroline, Dupuis, Luc · 2017 · Annals of Neurology
  76. Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis
    Yamadera, Misaki, Fujimura, Harutoshi, Inoue, Kimiko, Toyooka, Keiko, Mori, Chiaki, Hirano, Hiroshi, Sakoda, Saburo · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  77. Targeting angiogenin in therapy of amyotropic lateral sclerosis
    Hiroko Kishikawa, David Wu, Guo-fu Hu · 2008 · Expert Opinion on Therapeutic Targets
  78. A role for spinal cord hypoxia in neurodegeneration
    Elena Hernandez‐Gerez, Ian N. Fleming, Simon H. Parson · 2019 · Cell Death and Disease
  79. Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues
    Natasha Vassileff, Laura J. Vella, Harinda Rajapaksha, Mitch Shambrook, Amirmohammad Nasiri Kenari, Catriona McLean, Andrew Francis Hill, Lesley Cheng · 2020 · Cells
  80. ALS and Oxidative Stress: The Neurovascular Scenario
    Akshay Anand, Keshav Thakur, Pawan Kumar Gupta · 2013 · Oxidative Medicine and Cellular Longevity
  81. NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
    José Jiménez-Villegas, Laura Ferraiuolo, Richard J. Mead, Pamela J. Shaw, Antonio Cuadrado, Ana Isabel Rojo · 2021 · Free Radical Biology and Medicine
  82. ALS: Focus on purinergic signalling
    Cinzia Volonté, Savina Apolloni, Maria Teresa Carrı̀, Nadia D’Ambrosi · 2011 · Pharmacology & Therapeutics
  83. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
    Nadia D’Ambrosi, Mauro Cozzolino, Maria Teresa Carrı̀ · 2017 · Antioxidants and Redox Signaling
  84. Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients
    Yonghua Wu, Xu Yang, Xiaogang Li, Haining Wang, Tiancheng Wang · 2020 · Neurological Sciences
  85. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder
    Pınar Aydoğan Avşar, Ümit Işık, Evrim Aktepe, Faruk Kılıç, Duygu Kumbul Doğuç, Halil İbrahim Büyükbayram · 2020 · International Journal of Psychiatry in Clinical Practice
  86. Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
    Sebastian A. Lewandowski, Ingrid Nilsson, Linda Fredriksson, Peter Lönnerberg, Lars Muhl, Manuel Zeitelhofer, Milena Z. Adzemovic, Susanne Nichterwitz, Daniel A. Lawrence, Eva Hedlund et al. · 2015 · Acta Neuropathologica
  87. Angiogenin induces modifications in the astrocyte secretome: Relevance to amyotrophic lateral sclerosis
    Alexandra Skorupa, Serge Urbach, Oana Vigy, Matthew A. King, Séverine Chaumont‐Dubel, Jochen H.M. Prehn, Philippe Marin · 2013 · Journal of Proteomics
  88. Neurovascular Unit in Chronic Pain
    Beatrice Mihaela Radu, Placido Bramanti, Francesco Osculati, Maria‐Luiza Flonta, Mihai Radu, Giuseppe Bertini, Paolo Francesco Fabene · 2013 · Mediators of Inflammation
  89. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice
    Prashanthi Menon, Rashid Deane, Abhay P. Sagare, Steven M. Lane, Troy J. Zarcone, Michael R. O’Dell, Yan Chen, Berislav V. Zloković, Bradford C. Berk · 2010 · Brain Research
  90. Neurovascular Aspects of Amyotrophic Lateral Sclerosis
    Maria Carolina Oliveira, Diana G. Hernandez‐Ontiveros, Michael K. Louis, Alison E. Willing, Cesar V. Borlongan, Paul R. Sanberg, Júlio César Voltarelli, Svitlana N. Garbuzova-Davis · 2012 · International review of neurobiology
  91. Interferon-γ blocks signalling through PDGFRβ in human brain pericytes
    Deidre Jansson, Emma L. Scotter, Justin Rustenhoven, Natacha Coppieters, Leon C. D. Smyth, Robyn L. Oldfield, Peter Bergin, Edward W. Mee, E. Scott Graham, Richard L. M. Faull et al. · 2016 · Journal of Neuroinflammation
  92. Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
    Svitlana N. Garbuzova-Davis, Jared C. Ehrhart, Paul R. Sanberg, Cesar V. Borlongan · 2018 · International Journal of Molecular Sciences
  93. Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
    Eleni Christoforidou, Greig Joilin, Majid Hafezparast · 2020 · Journal of Neuroinflammation
  94. Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: Implications for the generation of neuropathic pain
    Gustavo Tenorio, Ashwini Kulkarni, Bradley J. Kerr · 2012 · Pain
  95. The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
    Di He, Yan Chun Xu, Mingsheng Liu, Liying Cui · 2023 · Aging and Disease
  96. A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain
    Abhay P. Sagare, Robert D. Bell, Alaka Srivastava, Jesse D. Sengillo, Itender Singh, Yoichiro Nishida, Nienwen Chow, Berislav V. Zloković · 2013 · Journal of Biological Chemistry
  97. Early gene expression changes in spinal cord from SOD1G93A Amyotrophic Lateral Sclerosis animal model
    G. P. de Oliveira, Chrystian Junqueira Alves, Gerson Chadi · 2013 · Frontiers in Cellular Neuroscience
  98. Phosphatase 2A Inhibition Affects Endoplasmic Reticulum and Mitochondria Homeostasis Via Cytoskeletal Alterations in Brain Endothelial Cells
    Ana I. Plácido, Cláudia Pereira, Sónia C. Correira, Cristina Carvalho, Catarina Resende Oliveira, Paula Isabel Moreira · 2016 · Molecular Neurobiology
  99. Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
    Svitlana N. Garbuzova-Davis, Crupa Kurien, Edward M. Haller, David J. Eve, Stephanie Navarro, George A. Steiner, Ajay Mahendrasah, Surafuale Hailu, Mohammed Khatib, Kayla J. Boccio et al. · 2019 · Scientific Reports
  100. Iron accumulation promotes TACE-mediated TNF-α secretion and neurodegeneration in a mouse model of ALS
    Jae Keun Lee, Jin Hee Shin, Byoung Joo Gwag, Eui‐Ju Choi · 2015 · Neurobiology of Disease